Literature DB >> 29792873

Effect of Alzheimer's disease risk and protective factors on cognitive trajectories in subjective memory complainers: An INSIGHT-preAD study.

Stefan J Teipel1,2, Enrica Cavedo3,4,5,6,7, Simone Lista3,4,5,6, Marie-Odile Habert8,9, Marie-Claude Potier10, Michel J Grothe1,2, Stephane Epelbaum4, Luisa Sambati4, Geoffroy Gagliardi4, Nicola Toschi11,12,13, Michael D Greicius14, Bruno Dubois4, Harald Hampel3,4,5,6.   

Abstract

INTRODUCTION: Cognitive change in people at risk of Alzheimer's disease (AD) such as subjective memory complainers is highly variable across individuals.
METHODS: We used latent class growth modeling to identify distinct classes of nonlinear trajectories of cognitive change over 2 years follow-up from 265 subjective memory complainers individuals (age 70 years and older) of the INSIGHT-preAD cohort. We determined the effect of cortical amyloid load, hippocampus and basal forebrain volumes, and education on the cognitive trajectory classes.
RESULTS: Latent class growth modeling identified distinct nonlinear cognitive trajectories. Education was associated with higher performing trajectories, whereas global amyloid load and basal forebrain atrophy were associated with lower performing trajectories. DISCUSSION: Distinct classes of cognitive trajectories were associated with risk and protective factors of AD. These associations support the notion that the identified cognitive trajectories reflect different risk for AD that may be useful for selecting high-risk individuals for intervention trials.
Copyright © 2018 the Alzheimer's Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Amyloid PET; Cholinergic basal forebrain; Hippocampus; Longitudinal cognitive change; Preclinical Alzheimer's disease

Mesh:

Substances:

Year:  2018        PMID: 29792873     DOI: 10.1016/j.jalz.2018.04.004

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  7 in total

1.  Subjective cognitive decline and rates of incident Alzheimer's disease and non-Alzheimer's disease dementia.

Authors:  Rosalinde E R Slot; Sietske A M Sikkes; Johannes Berkhof; Henry Brodaty; Rachel Buckley; Enrica Cavedo; Efthimios Dardiotis; Francoise Guillo-Benarous; Harald Hampel; Nicole A Kochan; Simone Lista; Tobias Luck; Paul Maruff; José Luis Molinuevo; Johannes Kornhuber; Barry Reisberg; Steffi G Riedel-Heller; Shannon L Risacher; Susanne Roehr; Perminder S Sachdev; Nikolaos Scarmeas; Philip Scheltens; Melanie B Shulman; Andrew J Saykin; Sander C J Verfaillie; Pieter Jelle Visser; Stephanie J B Vos; Michael Wagner; Steffen Wolfsgruber; Frank Jessen; Wiesje M van der Flier
Journal:  Alzheimers Dement       Date:  2018-12-13       Impact factor: 21.566

Review 2.  The characterisation of subjective cognitive decline.

Authors:  Frank Jessen; Rebecca E Amariglio; Rachel F Buckley; Wiesje M van der Flier; Ying Han; José Luis Molinuevo; Laura Rabin; Dorene M Rentz; Octavio Rodriguez-Gomez; Andrew J Saykin; Sietske A M Sikkes; Colette M Smart; Steffen Wolfsgruber; Michael Wagner
Journal:  Lancet Neurol       Date:  2020-01-17       Impact factor: 44.182

3.  Differences in Trajectories and Predictive Factors of Cognition over Time in a Sample of Cognitively Healthy Adults, in Zaragoza, Spain.

Authors:  Elena Lobo; Patricia Gracia-García; Antonio Lobo; Pedro Saz; Concepción De-la-Cámara
Journal:  Int J Environ Res Public Health       Date:  2021-07-02       Impact factor: 3.390

Review 4.  Distinct Cognitive Trajectories in Late Life and Associated Predictors and Outcomes: A Systematic Review.

Authors:  Zimu Wu; Aung Zaw Zaw Phyo; Tagrid Al-Harbi; Robyn L Woods; Joanne Ryan
Journal:  J Alzheimers Dis Rep       Date:  2020-10-24

5.  Trajectories of cognitive function in community-dwelling older adults: A longitudinal study of population heterogeneity.

Authors:  Zimu Wu; Robyn L Woods; Rory Wolfe; Elsdon Storey; Trevor T J Chong; Raj C Shah; Suzanne G Orchard; John J McNeil; Anne M Murray; Joanne Ryan
Journal:  Alzheimers Dement (Amst)       Date:  2021-05-02

6.  Quantifying the heterogeneity of cognitive functioning in Alzheimer's disease to extend the placebo-treatment dichotomy: Latent class analysis of individual-participant data from five pivotal randomized clinical trials of donepezil.

Authors:  Stephen Z Levine; Yair Goldberg; Kazufumi Yoshida; Myrto Samara; Andrea Cipriani; Takeshi Iwatsubo; Stefan Leucht; Toshiaki A Furawaka
Journal:  Eur Psychiatry       Date:  2021-02-15       Impact factor: 5.361

7.  In vivo staging of regional amyloid progression in healthy middle-aged to older people at risk of Alzheimer's disease.

Authors:  Fedor Levin; Irina Jelistratova; Tobey J Betthauser; Ozioma Okonkwo; Sterling C Johnson; Stefan J Teipel; Michel J Grothe
Journal:  Alzheimers Res Ther       Date:  2021-10-21       Impact factor: 8.823

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.